Kappa P. Meadows, M.D. Born: Tifton, Georgia September 3, 1966 U.S. Citizen Residence: Lynchburg, Virginia License #0101-225823
Education:
1999-2000 Faculty, University of Utah, Department of Dermatology Research Fellow, University of Utah, Department of Dermatology, Dr. Gerald Krueger
1996-1999 Dermatology University of Utah Affiliated Hospitals Salt Lake City, UT Residency
1995-1996 University of Utah Affiliated Hospitals Salt Lake City, UT Chief Medical Resident in Internal Medicine
1993-1995 University of Utah Affiliated Hospitals Salt Lake City, UT Resident in Internal Medicine
1992-1993 University of Utah Affiliated Hospitals Salt Lake City, UT Intern in Internal Medicine
1992 Medical College of Georgia Augusta, GA Doctor of Medicine
1988 Davidson College Davidson, NC B.S., Premedicine
Experience:
2003-Present Medical Director, The Education & Research Foundation, Inc. 2095 Langhorne Road, Lynchburg, Virginia 24501
2001-Present Investigator, The Education & Research Foundation, Inc. 2095 Langhorne Road, Lynchburg, Virginia 24501
2000-Present Private Practice, Dermatology Dermatology Consultants, Inc. Lynchburg, Virginia
2095 Langhorne Road, Lynchburg, VA 24501 • PH (434) 847-8400 • FX (434) 846-1707 www.educationandresearch.com Kappa P. Meadows, MD Page 2 of 5
Memberships: 2007-Present Dermatology Foundation Leadership Society – 2008-present 2000-Present Women’s Dermatological Society 2000-Present Medical Society of Virginia 1996-Present American Academy of Dermatology 1992-Present American College of Physicians 1988-Present American Medical Association Awards: February 2000 Women’s Dermatological Society Mentorship Award to study ethnic skin disorders with Dr. Calvin McCall Grady Hospital/Emory University, Atlanta, GA Publications: Articles: 1. Meadows, KP, Tyring SK, Pavia AT, Rallis TM. Resolution of Recalcitrant Molluscum Contagiosum Virus Lesions in Human Immunodeficiency Virus-Infected Patients Treated with Cidofovir. Arch. Dermatol. 133:987-990, 1997. 2. Egan CA, Meadows KP, Zone JJ. Ulcerative colitis and immunobullous disease cured by colectomy. Arch. Dermatol. 135:214-215, 1999. 3. Egan CA, Rallis TM, Meadows KP, Krueger GG. Low dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx eczema. J. Am. Acad. Dermatol. 40:612-614, 1999. 4. Egan CA, Rallis TM, Meadows KP, Krueger GG. Rosacea induced by Beclomethasone Dipropionate nasal spray. Int. J. Dermatol. 38:131-141, 1999. 5. Meadows KP, Egan CA. Vesicular carcinoma erysipelatodes. J. Am. Acad. Dermatol. 40:805-807, 1999. 6. Egan CA, O’Reilly MA, Meadows KP, Zone JJ. Relapsing Henoch-Schonlein Purpura associated with pyelonephritis due to Pseudomonas aeruginosa. J. Am. Acad. Dermatol. 42 (2):381-383, 2000. 7. Egan CA, Meadows KP, Zone JJ. Plasmapheresis as a steroid saving procedure in bullous pemphigoid. Int. J. Dermatol. April, 2000. 8. Meadows KP, Egan CA, Vanderhooft SL. Pathological case of the month: Proteus syndrome. Arch. Pediatr. Adol. Med. 154:527-528, 2000. 9. Meadows KP, Egan CA, Vanderhooft SL. Acute Generalized Exanthematous Pustulosis (AGEP), an Uncommon Condition in Children: Case Report and Review of the Literature. Pediatr. Dermatol. 17:399-402, 2000. 10. Egan CA, Meadows KP, VanOrman CB, Vanderhooft SL. Neurologic variant of epidermal nevus syndrome with a facial lipoma. Int. J. Dermatol. 40(3)::189-190, Mar, 2001. 11. O’Reilly MA, Meadows KP, Egan CA. Off-Center Fold: necrotizing livedo reticularis. Diagnosis: primary hyperoxaluria Type 1. Arch. Dermatol. 137(7)::957-62, July 2001. 12. Tristani-Firouzi, FP, Meadows KP, Vanderhooft SL. Pigmented Purpuric Eruptions of Childhood: a series of cases and review of literature. Pediatric Dermatol. 18(4)::299-304, July-Aug. 2001. 13. Meadows KP, O'Reilly, MA, Harris, RM, Petersen, MJ. Erythematous annular plaques in a neclace distribution. Annular elastolystic giant cell granuloma. Arch. Dermatol. 137(12)::1647-53, Dec. 2001.
14JUN2017 Kappa P. Meadows, MD Page 3 of 5
14. Fowler J, Jarratt M, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M. Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment of moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studies. Br J Dermatol. 2012 Mar; 166(3): 633-641. 15. Fowler J, Jackson M, Moore A, Jarratt M, Jones T, Meadows K, Steinhoff M, Rudisill D, Leoni M. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. J Drugs Dermatol. 2013 Jun 1: 12(6):650-6. Electronic Data Capture Training: 2016 Inform 6.0, eCaselink 2014 Medidata Rave, Medidata Balance, Inform 2013-4 Inform 2012 Datalabs 5.1 2012 Inform GTM 5.0 2009, 2010, 2011 Medidata Rave Continuing Education/Training: 2017 Investigator IGA and Lesion Counting Study Specific for Acne 2016 Clinical Assessments of Tinea Pedis Study Specific for Tinea Pedis 2016 Good Clinical Practices (most recent) Study Specific Investigator Meeting 2016 Clinician Reported Photonumeric Cellulite Severity Scale for Thigh & Buttock Study Specific for Cellulite 2015 Investigator Global Assessment (IGA) and Lesion Counting Study Specific for Acne 2015 Investigator Global Assessment, BSA and Target Lesion Signs of Psoriasis Study Specific for Psoriasis 2014-2015 General Sponsor Training ICH GCP Investigator Training Investigator Safety Training Safety Reporting in Clinical Studies GCP Training for Investigator and Study Site Staff 2014 Investigator Global Assessment, BSA and Target Lesion Signs of Psoriasis Study Specific for Psoriasis 2012-2014 Evaluator Global Assessments (EGSS) and Lesion Count Assessments Harmonization Study Specific for Acne 2014 University Health Services Professional Education Programs (UHS-PEP) of Virginia Commonwealth University Health System NIH Protecting Human Research Participants Course – an Enduring Material 2014 The National Institutes of Health (NIH) (most recent) Protecting Human Research Participants
14JUN2017 Kappa P. Meadows, MD Page 4 of 5
Continuing Education/Training (Cont’d): 2013 PASI/BSA/sPGA Training Modules Study Specific for Psoriasis 2013 The Morehouse School of Medicine Site Solutions Summit 2012 HealthStream “ABMS® Patient Safety Foundations” 2012 The NIH Office of Clinical Research Training and Medical Education Clinical Research Training 2011 Investigator’s Global Assessment (IGA) and Lesion Counting Harmonization Study Specific for Rosacea 2011 “Guide to Good Clinical Practice” Monthly Newsletters Thompson Publishing Group, Inc. 2010 Clinician’s Erythema Assessment (CEA) Harmonization Study Specific for Rosacea 2010 Intraocular Pressure (IOP) Measurement (Reichert Tono-Pen) 2007 Association of Clinical Research Professionals (ACRP) Global Conference in Seattle, WA Regulatory Documents: A-Z How to Prepare for an FDA Audit SOP Development Process Good Clinical Research & HIPPA Quality Assessment Forum—Clinical Trials at Small Investigative Site 2006-Present Acne Grading Study Specific Training Study Experience: Phase I: Repeat Insult Patch Test Modified Repeat Insult Patch Test 21 Day Cumulative Irritation Phases II, III, IV: Cellulite Common Warts Mild to Severe Acne (topical and light therapy) Actinic Keratosis Seborrheic Keratosis Psoriasis (topical and biologic) Atopic Dermatitis/Eczema (topical) Onychomycosis (topical and systemic) Mild to Severe Dandruff (topical and systemic) Basal Cell Carcinoma Squamous Cell Carcinoma Solar Lentigines Light Based Hair Removal Rosacea Aging Skin Alopecia Tinea Pedis Tinea Cruris
14JUN2017 Kappa P. Meadows, MD Page 5 of 5
Post-Marketing: Psoriasis (biologic) Eczema (biologic) OTC, Device, Other.: Skin Biopsies Hair Growth Healthy Skin Shoe Insoles/Inserts Use-Irritancy (antiperspirants, shave gels, depilatories, cosmetics, etc.) Mild to Severe Dandruff (topical) Constipation Dry Skin (Perception) Injectable Product - Safety Analysis Hemorrhoids/Anal Fissures Label Comprehension Skin Tags Warts Nickel Allergy Infants/Babies/Toddlers (Safety & Efficacy)
14JUN2017